CANCER 52

Registered charity 1174569 · accounts filings on the Charity Commission register

To promote and protect the health and sufferers of rare and less common cancers for the public benefit by :(a) Promoting understanding, awareness and research about rare and less common cancers(b) acting as a collective voice and advocating needs of individuals affected by a rare or less common cancers(c)supporting not-for-profit organisations in field of rare and less common cancers

Causes: General Charitable Purposes · The Advancement Of Health Or Saving Of Lives · Other Charitable Purposes · website · Get email alerts

Latest income
£363k
Latest spending
£349k
Registered
2017
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that Cancer52 generated a surplus of £14,819 for the year ended 31 March 2025, with total income of £363,420 against expenditure of £348,601. Per the trustees' report, unrestricted reserves increased to £65,732, which the Board considers sufficient to cover five months of operational running costs in line with their stated policy of holding between five and seven months' expenditure.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Reserves policy: five to seven months' unrestricted annual expenditure (held: £66k)
This means that we aim to hold between five and seven months’ unrestricted annual expenditure in reserve.
Per its FY2025 accounts as filed with the Charity Commission.

Accounts independently examined (not a full audit). Discloses 5 of 6 completeness components.

Public profiles (found on the charity’s own website): facebook

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Northern Ireland · Scotland · Throughout England And Wales

Income and spending

Financial year endIncomeSpending
31/03/2025£363k£349k
31/03/2024£231k£269k
31/03/2023£177k£198k
31/03/2022£145k£151k
31/03/2021£176k£126k

Common questions

Is CANCER 52 financially healthy?

Per its FY2025 accounts: The accounts state that Cancer52 generated a surplus of £14,819 for the year ended 31 March 2025, with total income of £363,420 against expenditure of £348,601. Per the trustees' report, unrestricted reserves increased to £65,732, which the Board considers sufficient to cover five months of operational running costs in line with their stated policy of holding between five and seven months' expenditure. Its FY2025 accounts were independently examined.

Government & lottery funding

Grants to this charity published as open data by government and lottery funders (360Giving).

FunderDateAmountPurpose
The National Lottery Community Fund31/08/2023£466kSupporting Cancer52's organisational development and growth